Novartis AG (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 144   

Articles published

NVS 97.11 -1.82 (-1.84%)
price chart
Investors Sell Novartis AG (ADR) on Price Strength
Novartis AG (ADR) (NYSE:NVS) had an uninteresting session and gained 2.44 points till last call. The price was at $98.93, gaining 2.53% till the last intraday data.
First Call Rating Update on Novartis AG (ADR)  Stafford Daily
Novartis AG (ADR) Earnings Revenue Update  Rock Hill Daily
Stock To Watch : Novartis AG (ADR)(NYSE:NVS)
Novartis AG (ADR)(NYSE:NVS) (TREND ANALYSIS) shares are still trading near the 52-week high of $102.59. The stock closed last trading session at $101.48, with a volume of 1,334,174 shares against an average volume for the last 3 months of 1,498,780.
Novartis AG (ADR) Investors Book Profit on Strength  Bar and Graph Report
Brokerage Firm Price Target on Novartis AG (ADR)  Stafford Daily
Novartis AG (ADR) (NVS)'s Cosentyx Gets Clearance In Europe
Novartis AG (ADR) (NYSE:NVS)'s Cosentyx� gets the European Commission approval to be the first-line treatment of moderate-to-severe plaque psoriasis in adults requiring systemic therapy.
Stock Watch: Novartis AG (ADR) (NYSE:NVS), MGIC Investment Corp. (NYSE ...  Realist Investor
Novartis Gets European Approval For Potential Blockbuster Cosentyx  Bidness ETC
Novartis AG ADR (NVS): New Analyst Report from Zacks Equity Research ...
Novartis reported third-quarter 2014 earnings per share of $1.33, up 48% from the year-ago period. Core earnings per share came in at $1.37, up 10% from the year-ago period and beat the Zacks Consensus Estimate of $1.29.
Related articles »  
Options Check-Up: Bristol-Myers Squibb, Merck & Co., and Novartis AG
Among the stocks attracting attention from options traders lately are pharmaceutical firms Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co.
Novartis AG (ADR) Witness Large Outflow of Money
Shares of Novartis AG (ADR) (NYSE:NVS) advanced slightly to $96.95. The price had gained 0.08% or 0.08 points intraday.
Analyst Price Target Consensus on Novartis AG (ADR)
In a research note released to the investors, Cowen & Company upgrades its rating on Novartis AG (ADR) (NYSE:NVS).
Bullish and Outperform S&P 500: Eldorado Gold Corp (USA) , Novartis AG (ADR)
Shares of Eldorado Gold Corp (USA) (NYSE:EGO) rose by 9.64% in the past week and 15.11% for the past 4 weeks. For the past week, the counter has outperformed the S&P 500 by 11.02% and the outperformance increases to 18.03% for the past 4 weeks.
Investors Book Profit on the Price Strength of Novartis AG (ADR)
Novartis AG (ADR) (NYSE:NVS) managed to stay afloat and traded higher with an addition of 0.03 point or 0.03% at $96.87.
Novartis AG Anticipates Price War With Amgen, Eli Lilly & Co. Over Psoriasis Drugs
Swiss pharmaceutical giant Novartis AG (ADR) (NYSE:NVS) sees a potential price war with Amgen, Inc. (NASDAQ:AMGN) and Eli Lilly & Co.